Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDSHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, myelodysplastic syndromeRecruitingPhase 22023-12-05NCT05788679

2 results · Page 1 of 1

Swipe the table sideways for more columns.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Department of Hematology, Karolinska University HospitalStockholmSweden1